臨床検査55巻5号

2011年05月発行

今月の主題 癌幹細胞と検査医学 各論

膵癌

著者： 小池博之¹ 中田晋¹ 谷口英樹¹

所属機関： ¹横浜市立大学大学院医学研究科臓器再生医学

ページ範囲：P.495 - P.499

膵癌は既存の治療法に強い抵抗性を示し，極めて予後が悪い．近年，膵癌中に幹細胞の性質をもつ，いわゆる癌幹細胞が少数存在し，治療抵抗性に寄与しているというモデルが提唱されている．膵癌の治療抵抗性にかかわる膵癌幹細胞の同定は，有効な膵癌の治療法を開発するうえで重要と考えられる．

参考文献

1) Li C, Heidt DG, Dalerba P, et al:Identification of pancreatic cancer stem cells. Cancer Res　67：1030-1037，2007

2) Hermann PC, Huber SL, Herrler T, et al:Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell　1：313-323，2007

3) Hong SP, Wen J, Bang S, et al:CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells. Int J Cancer　125：2323-2331，2009

4) Mueller MT, Hermann PC, Witthauer J, et al:Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. Gastroenterology　137：1102-1113，2009

5) Shah AN, Summy JM, Zhang J, et al:Development and characterization of gemcitabine-resistant pancreatic tumor cells. Ann Surg Oncol　14：3629-3637，2007

6) Feldmann G, Dhara S, Fendrich V, et al:Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases:a new paradigm for combination therapy in solid cancers. Cancer Res　67：2187-2196，2007

7) Jimeno A, Feldmann G, Suarez-Gauthier A, et al:A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development. Mol Cancer Ther　8：310-314，2009

8) Rasheed ZA, Yang J, Wang Q, et al:Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst　102：340-351，2010

9) Kondo T, Setoguchi T, Taga T:Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA　101：781-786，2004

10) Wang YH, Li F, Luo B, et al:A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. Neoplasma　56：371-378，2009

11) Dylla SJ, Beviglia L, Palk IK, et al:Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One　3：e2428，2008

progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacities. Cancer Res　60：4403-4411，2000

13) Soeda A, Park M, Lee D, et al:Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α. Oncogene　28：3949-3959，2009

14) Kaanders JH, Wijffels KI, Marres HA, et al:Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res　62：7066-7074，2002

15) Bao S, Wu Q, McLendon RE, et al:Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature　444：756-760，2006

breast cancer-initiating cells to radiation. J Natl Cancer Inst　98：1777-1785，2006